Cytotoxicity against autologous, allogeneic, and xenogeneic tumor targets by human recombinant interleukin-2-activated lymphocytes from healthy dogs and dogs with lung tumors. [electronic resource]
Producer: 19911017Description: 1132-6 p. digitalISSN:- 0002-9645
- Adenocarcinoma -- therapy
- Animals
- Cytotoxicity, Immunologic
- Dog Diseases -- therapy
- Dogs
- Immunotherapy, Adoptive
- Interleukin-2 -- pharmacology
- Killer Cells, Lymphokine-Activated -- immunology
- Lung Neoplasms -- secondary
- Lymphocytes -- immunology
- Male
- Osteosarcoma -- secondary
- Recombinant Proteins -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.